Back to Authors

Paul, Dawn Carmel

A5006511239

Mayo Clinic

Celgene Corporation, Summit, USA

Citations 1

P661 Early histological improvement demonstrated with oral ozanimod in patients with moderately to severely active Crohn’s disease in the STEPSTONE trial

Journal of Crohn's and Colitis | January 25, 2019 | Volume: 13 | Issue: Supplement_1 | Pages: S450-S450

10.1093/ecco-jcc/jjy222.785